Posted: June 2017 By Νiki Karachaliou, MD, PhD The identification of oncogenic driver alterations in non-small cell lung cancer (NSCLC), such as EGFR mutations and ALK rearrangements, each of which […] Read more
IASLC International Mentorship Program Boosts Early Careers, Fosters International Collaboration
Posted: April 2017 By Keightley Amen, BA, ELS To help ensure that high-quality thoracic oncology care is available throughout the world and well into the future, the IASLC offers an […] Read more
Innovations in the 8th Edition of the TNM Classification of Lung Cancer Enhance Prognostic Capabilities
Posted: April 2017 By Cynthia L. Kryder, MS, CCC-Sp, with Ramón Rami-Porta, MD Clinicians around the world began implementing the 8th edition of the tumor, node, and metastasis (TNM) classification […] Read more
Lung Cancer in Never-Smokers: An Epidemiologic Perspective
Daniel S.W. Tan, MD, PhD+more
Posted: February 2017 By Chee-Keong Toh, MD, and Daniel SW Tan, MD The recent decade has seen much interest in lung cancer in never-smokers (LCNS), in most part attributed to […] Read more
By Julien Mazières, MD, PhD, and Julie Milia, PhD Once considered a “man’s disease,” lung cancer no longer discriminates. During the last decade, lung cancer in women has become the […] Read more
By Jyoti Malhotra, MD, MPH and Paolo Boffetta, MD, MPH Lung cancer is the most frequent malignant neoplasm in most countries worldwide, and the main cause of cancer death in […] Read more
Posted: November 1, 2016 How one investigator’s passion and devotion to science led to discovery of the “ghost gene” in MPM Q&A with Michele Carbone, MD Q: Many laboratories are […] Read more
By Cynthia L. Kryder, MS IASLC Lung Cancer News recently spoke with Kapil Dhingra, MD, of KAPital Consulting LLC in Sparta, New Jersey, about oncologic drug development and the challenges […] Read more
Next-Generation Sequencing Across the World: Reports from France, Germany, and China
Next-generation sequencing (NGS) technology has revolutionized genomic and genetic research as it fulfills its potential to tailor the treatment of cancer patients in general and non-small cell lung cancer (NSCLC) […] Read more
By Adi F. Gazdar, MD While all of the major histological forms of lung cancer are strongly associated with smoking, an important subset (about 20% worldwide, 10–15% in the US) […] Read more